Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications

Area of Science:

• Molecular Biology
• Epigenetics
• Cancer Research

Background:

• Polycomb group (PcG) proteins are essential transcriptional repressors governing cell development.
• PcG protein deregulation is implicated in human carcinogenesis, affecting proliferation, apoptosis, and cancer stem cells.
• Research has traditionally focused on PcG functions, but non-classical roles are emerging.

Purpose of the Study:

• To review recent advances in understanding PcG proteins' roles in cancer.
• To elucidate the mechanisms of PcG proteins in cancer initiation, development, and progression.
• To discuss the potential of PcG proteins as cancer biomarkers and therapeutic targets.

Main Methods:

• Literature review of genetic and molecular investigations on PcG proteins.
• Analysis of PcG-dependent and independent functions in cancer.
• Synthesis of findings on PcG proteins' involvement in oncogenes and tumor suppressors.

Main Results:

• PcG proteins exhibit both classical repressive and non-classical functions in cancer.
• PcG proteins regulate oncogenes and tumor suppressors independently of their classical PcG functions.
• PcG protein status is associated with patient survival and cancer progression.

Conclusions:

• PcG proteins play multifaceted roles in cancer initiation and progression through both classical and non-classical mechanisms.
• PcG proteins hold significant potential as biomarkers for cancer diagnosis and prognosis.
• Targeting PcG proteins represents a promising strategy for novel cancer therapies.